Deze pagina is automatisch vertaald en de nauwkeurigheid van de vertaling kan niet worden gegarandeerd. Raadpleeg de Engelse versie voor een brontekst.

Illuminated Chopper in Cataract Surgery (IChopper)

28 september 2026 bijgewerkt door: YES Eye Clinic

Prospective Randomized, Paired-Eye, Comparative Study Between Cataract Surgeries With and Without an Illuminated Chopper

This study compares cataract surgery performed with an illuminated chopper and intracameral illumination with cataract surgery performed under conventional external coaxial microscope illumination. Participants undergoing bilateral cataract surgery will have one eye treated with the illuminated chopper and the other eye treated without the illuminated chopper, with the order randomized between eyes.

The study will evaluate differences in operation time, pupil size, the need for additional intraocular medications or devices, intraoperative and postoperative complications, and postoperative clinical outcomes including visual acuity and intraocular pressure.

Studie Overzicht

Gedetailleerde beschrijving

This is a prospective, randomized, paired-eye comparative clinical study in participants undergoing bilateral cataract surgery. Each participant will undergo cataract surgery in both eyes. One eye will be treated using the iChopper illumination chopper with the iVision light source, while the fellow eye will undergo cataract surgery using conventional external coaxial microscope illumination. The order of the surgical method between the right and left eyes will be randomized.

The illuminated chopper provides intracameral illumination during cataract surgery and is designed to improve visualization of intraocular structures while also functioning as a lens chopper. The investigational device has received U.S. FDA 510(k) clearance.

The study will assess intraoperative outcomes including operation time, pupil size, ultrasound usage time, pupil-related surgical difficulties, intraoperative complications, and the use of additional intraocular medications or devices. Postoperative assessments will include visual acuity, manifest refraction, intraocular pressure, and postoperative complications.

Participants will undergo bilateral cataract surgery with the two procedures scheduled approximately 1 to 3 weeks apart. Follow-up assessments will be performed approximately 1 day and 30 days after surgery for each eye.

Studietype

Ingrijpend

Inschrijving (Werkelijk)

28

Fase

  • Niet toepasbaar

Contacten en locaties

In dit gedeelte vindt u de contactgegevens van degenen die het onderzoek uitvoeren en informatie over waar dit onderzoek wordt uitgevoerd.

Studie Locaties

    • Florida
      • Cape Coral, Florida, Verenigde Staten, 33904
        • Tyson Eye

Deelname Criteria

Onderzoekers zoeken naar mensen die aan een bepaalde beschrijving voldoen, de zogenaamde geschiktheidscriteria. Enkele voorbeelden van deze criteria zijn iemands algemene gezondheidstoestand of eerdere behandelingen.

Geschiktheidscriteria

Leeftijden die in aanmerking komen voor studie

40 jaar en ouder (Volwassen, Oudere volwassene)

Accepteert gezonde vrijwilligers

Nee

Geslachten die in aanmerking komen voor studie

Allemaal

Beschrijving

Inclusion Criteria:

  • Age 40 years or older
  • Diagnosis of bilateral cataract
  • Both eyes suitable for cataract surgery
  • Expected postoperative best-corrected visual acuity of 0.2 Snellen or better
  • No other secondary ocular surgeries planned during the study period
  • Ability to comply with all study procedures and follow-up visits
  • Ability and willingness to provide written informed consent

Exclusion Criteria:

  • Preoperative ocular or systemic conditions, or medication use, that may affect study outcomes, increase risk to the participant, or predispose to complications, including infectious disease, ocular atrophy, or zonular weakness
  • Poorly controlled diabetes mellitus
  • Use of alpha-blockers such as tamsulosin for benign prostatic hyperplasia
  • Planned femtosecond laser-assisted cataract surgery
  • Congenital ocular disorders
  • History of ophthalmic surgery in either eye that may affect study outcomes or increase risk, including retinal surgery, glaucoma surgery, or anterior segment surgery
  • Inability to provide informed consent
  • Pregnancy

Studie plan

Dit gedeelte bevat details van het studieplan, inclusief hoe de studie is opgezet en wat de studie meet.

Hoe is de studie opgezet?

Ontwerpdetails

  • Primair doel: Behandeling
  • Toewijzing: Gerandomiseerd
  • Interventioneel model: Parallelle opdracht
  • Masker: Enkel

Wapens en interventies

Deelnemersgroep / Arm
Interventie / Behandeling
Experimenteel: Illuminated Chopper in Right Eye

Participants assigned to this arm undergo cataract surgery using the illuminated chopper in the right eye and cataract surgery under conventional external coaxial microscope illumination in the left eye.

Cataract surgery is performed using the iChopper illumination chopper with the iVision light source to provide intracameral illumination during phacoemulsification.

Cataract surgery is performed under conventional external coaxial illumination from the surgical microscope without use of the illuminated chopper.

Experimenteel: Illuminated Chopper in Left Eye

Participants assigned to this arm undergo cataract surgery under conventional external coaxial microscope illumination in the right eye and cataract surgery using the illuminated chopper in the left eye.

Cataract surgery is performed using the iChopper illumination chopper with the iVision light source to provide intracameral illumination during phacoemulsification.

Cataract surgery is performed under conventional external coaxial illumination from the surgical microscope without use of the illuminated chopper.

Wat meet het onderzoek?

Primaire uitkomstmaten

Uitkomstmaat
Maatregel Beschrijving
Tijdsspanne
Operation Time
Tijdsspanne: During cataract surgery

Operation time during cataract surgery will be recorded and compared between eyes undergoing surgery with the illuminated chopper and eyes undergoing surgery with conventional microscope illumination.

During cataract surgery
Pupil Size During Cataract Surgery
Tijdsspanne: During cataract surgery

Pupil size during cataract surgery will be assessed and compared between the illuminated chopper and conventional microscope illumination conditions.

During cataract surgery
Use of Additional Intraocular Medications
Tijdsspanne: During cataract surgery

The use of additional intraocular medications during cataract surgery will be recorded and compared between the illuminated chopper and conventional microscope illumination conditions.

During cataract surgery
Use of Additional Intraocular Devices
Tijdsspanne: During cataract surgery

The use of additional intraocular devices during cataract surgery will be recorded and compared between the illuminated chopper and conventional microscope illumination conditions.

During cataract surgery

Secundaire uitkomstmaten

Uitkomstmaat
Maatregel Beschrijving
Tijdsspanne
Intraoperative Complications
Tijdsspanne: During cataract surgery

Intraoperative complications occurring during cataract surgery, including pupil-related and other surgical complications, will be recorded and compared between the two surgical conditions.

During cataract surgery
Postoperative Complications
Tijdsspanne: From surgery through approximately 30 days after surgery

Postoperative complications following cataract surgery will be recorded and compared between eyes treated with and without the illuminated chopper.

From surgery through approximately 30 days after surgery
Postoperative Distance Visual Acuity
Tijdsspanne: Day 1 and Day 30 after surgery

Distance visual acuity will be assessed after cataract surgery and compared between the illuminated chopper and conventional microscope illumination conditions.

Day 1 and Day 30 after surgery
Postoperative Intraocular Pressure
Tijdsspanne: Day 1 and Day 30 after surgery

Intraocular pressure will be assessed during postoperative follow-up and compared between the illuminated chopper and conventional microscope illumination conditions.

Day 1 and Day 30 after surgery

Andere uitkomstmaten

Uitkomstmaat
Maatregel Beschrijving
Tijdsspanne
Incidence of Adverse Events
Tijdsspanne: From surgery through approximately 30 days after surgery

The incidence of adverse events following cataract surgery will be assessed, including cystoid macular edema, endophthalmitis, lens luxation, pupillary block, retinal detachment, and persistent elevation of intraocular pressure requiring treatment.

From surgery through approximately 30 days after surgery
Incidence of Postoperative Ocular Complications
Tijdsspanne: From surgery through approximately 30 days after surgery

Ocular complications will be assessed, including flat anterior chamber, vitreous in the anterior chamber, residual lens material, intraocular lens decentration or tilt, posterior capsular fibrosis or opacity, and intraocular pressure elevation requiring treatment.

From surgery through approximately 30 days after surgery

Medewerkers en onderzoekers

Hier vindt u mensen en organisaties die betrokken zijn bij dit onderzoek.

Sponsor

Onderzoekers

  • Studie directeur: Dong Heun Nam, MD, PhD, Gachon University Gil Medical Center, College of Medicine, Incheon, Republic of Korea

Studie record data

Deze datums volgen de voortgang van het onderzoeksdossier en de samenvatting van de ingediende resultaten bij ClinicalTrials.gov. Studieverslagen en gerapporteerde resultaten worden beoordeeld door de National Library of Medicine (NLM) om er zeker van te zijn dat ze voldoen aan specifieke kwaliteitscontrolenormen voordat ze op de openbare website worden geplaatst.

Bestudeer belangrijke data

Studie start (Werkelijk)

14 september 2023

Primaire voltooiing (Werkelijk)

7 maart 2024

Studie voltooiing (Werkelijk)

7 maart 2024

Studieregistratiedata

Eerst ingediend

19 september 2026

Eerst ingediend dat voldeed aan de QC-criteria

19 september 2026

Eerst geplaatst (Werkelijk)

25 september 2026

Updates van studierecords

Laatste update geplaatst (Werkelijk)

2 oktober 2026

Laatste update ingediend die voldeed aan QC-criteria

28 september 2026

Laatst geverifieerd

1 september 2026

Meer informatie

Termen gerelateerd aan deze studie

Aanvullende relevante MeSH-voorwaarden

Andere studie-ID-nummers

  • OCL-IIC-01
  • RS-2022-00141533 (Ander subsidie-/financieringsnummer: The Korean government (the Ministry of Science and ICT; the Ministry of Trade, Industry, and Energy))

Plan Individuele Deelnemersgegevens (IPD)

Bent u van plan om gegevens van individuele deelnemers (IPD) te delen?

JA

Beschrijving IPD-plan

De-identified individual participant data may be shared with qualified researchers upon reasonable request after publication, subject to review by the study investigators and sponsor and in accordance with applicable ethical, privacy, and regulatory requirements.

IPD-tijdsbestek voor delen

Beginning after publication of the primary study results and available for 5 years thereafter.

IPD-toegangscriteria voor delen

Data will be made available to qualified researchers who submit a reasonable and scientifically sound request. Requests will be reviewed by the study investigators and sponsor. Access will be provided for approved research purposes, subject to appropriate data use agreements and compliance with applicable ethical, privacy, and regulatory requirements.

IPD delen Ondersteunend informatietype

  • LEERPROTOCOOL

Informatie over medicijnen en apparaten, studiedocumenten

Bestudeert een door de Amerikaanse FDA gereguleerd geneesmiddel

Nee

Bestudeert een door de Amerikaanse FDA gereguleerd apparaatproduct

Ja

product vervaardigd in en geëxporteerd uit de V.S.

Nee

Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .

Abonneren